Potential out-of-pocket costs for patients requiring hospitalization for COVID-19

By Stoddard Davenport
02 April 2020
Download PDF 0.2MB

Although it is too early to analyze actual healthcare cost data for those who have been treated for COVID-19 in the United States, historical data from patients who have sought medical attention for influenza or pneumonia may be informative for understanding patient out-of-pocket costs due to treatment for COVID-19. The biological and clinical characteristics of COVID-19 differ from other respiratory infections, but the signs and symptoms that necessitate hospitalization and intensive care for severe cases of the disease are also seen in severe cases of other respiratory infections. In this report, we used healthcare claims data from three large, national research databases to investigate the variation in out-of-pocket costs for patients who historically experienced acute inpatient hospitalizations involving treatment of acute respiratory infections (pneumonia and influenza).

Download the infographic

Explore more tags from this article

thought leadership healthcare healthcare costs

About the Author(s)

Stoddard Davenport

Denver Tel: 1 303 2999400

View bio
INSIGHT

Related Milliman Insight

Article

Multiemployer Review: Failing to meet benchmarks by the end of a funding improvement or rehabilitation period

What are the potential penalties if a multiemployer pension plan reaches the end of its funding improvement plan or rehabilitation plan period and falls short of the goals?

Read more

We’re here to help

Ask the tough questions. We’re ready for them.

Contact an expert